Antithrombotic Medication for Cardioembolic Stroke Prevention
Open Access
- 1 January 2011
- journal article
- Published by Hindawi Limited in Stroke Research and Treatment
- Vol. 2011, 1-23
- https://doi.org/10.4061/2011/607852
Abstract
Embolism of cardiac origin accounts for about 20% of ischemic strokes. Nonvalvular atrial fibrillation is the most frequent cause of cardioembolic stroke. Approximately 1% of population is affected by atrial fibrillation, and its prevalence is growing with ageing in the modern world. Strokes due to cardioembolism are in general severe and prone to early recurrence and have a higher long-term risk of recurrence and mortality. Despite its enormous preventive potential, continuous oral anticoagulation is prescribed for less than half of patients with atrial fibrillation who have risk factors for cardioembolism and no contraindications for anticoagulation. Available evidence does not support routine immediate anticoagulation of acute cardioembolic stroke. Anticoagulation therapy's associated risk of hemorrhage and monitoring requirements have encouraged the investigation of alternative therapies for individuals with atrial fibrillation. New anticoagulants being tested for prevention of stroke are low-molecular-weight heparins (LMWH), unfractionated heparin, factor Xa inhibitors, or direct thrombin inhibitors like dabigatran etexilate and rivaroxaban. The later exhibit stable pharmacokinetics obviating the need for coagulation monitoring or dose titration, and they lack clinically significant food or drug interaction. Moreover, they offer another potential that includes fixed dosing, oral administration, and rapid onset of action. There are several concerns regarding potential harm, including an increased risk for hepatotoxicity, clinically significant bleeding, and acute coronary events. Therefore, additional trials and postmarketing surveillance will be needed.This publication has 159 references indexed in Scilit:
- Twenty-Year Trends in the Incidence of Stroke Complicating Acute Myocardial InfarctionJAMA Internal Medicine, 2008
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndromeAmerican Heart Journal, 2004
- Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II projectAmerican Heart Journal, 2004
- Low incidence of stroke in ambulatory patients with heart failure: A prospective studyAmerican Heart Journal, 1993
- Preliminary Report of the Stroke Prevention in Atrial Fibrillation StudyThe New England Journal of Medicine, 1990
- Prevalence of Patent Foramen Ovale in Patients with StrokeThe New England Journal of Medicine, 1988
- Nonbacterial thrombotic endocarditis: A reviewAmerican Heart Journal, 1987
- Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart ValvesThe New England Journal of Medicine, 1986
- Systemic arterial embolism in rheumatic heart diseaseAmerican Heart Journal, 1951